Provider review

Pallas Health review

Names six pharmacies and two NPIs — and sells only a 12-week prepay

The disclosure is the best here; the "$199/mo average" beside it is $597 billed every 12 weeks divided by three, and no monthly rung exists to choose instead.

Verified August 2026Partner

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

Visit Pallas Health

On this page

The verdict

Pallas answers questions most of this category will not. It names all six pharmacies that might fill your prescription, explains the 503A/503B distinction rather than leaving you to look it up, publishes two prescribing physicians' NPI numbers with a link to the federal registry to check them, and states its coverage state by state instead of claiming fifty in a slogan. Its marketing price is also its checkout price, which sounds like a low bar until you read what else is here. The catch is the billing shape. There is no month-to-month option and no term selector at all: compounded semaglutide is $139 for the first four weeks and then $597 every twelve weeks, tirzepatide $179 then $897, so the second charge is the full quarterly figure four weeks after the first. The advertised "$199/month" and "$299/month" are those figures divided by three — and the cycle is 84 days, which comes round 4.35 times a year rather than four, so on Pallas's own published renewal terms the ongoing cost is nearer $216 and $325. That is arithmetic on their numbers, not an accusation: twelve-weeks-equals-three-months is ordinary industry shorthand, and it happens to favor the seller by about 8.7%.

Pallas Health appears on our tirzepatide provider ranking and our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

You want to know who dispenses your medication and who prescribes it, and you will actually look them up — six named pharmacies and two verifiable NPI numbers is more to check than almost anything else here publishes
You can absorb a $597 charge four weeks after a $139 one, and a quarterly rhythm suits you better than a monthly one
You want a compounded and a brand-name route from one desk: Zepbound, Ozempic, Wegovy and Mounjaro are sold alongside the compounded line and billed monthly
You live in one of the 43 states where the whole thing is asynchronous and you would rather not book a video visit

Look elsewhere if

You want to buy a month, try it, and stop — there is no month-to-month rung at any price, and canceling still leaves you paid up through a twelve-week block
You are budgeting off the advertised "/mo" figure: the real ongoing cost is about 8.7% higher, because the charge recurs 4.35 times a year rather than four
You are shopping for peptides rather than GLP-1s — Pallas sells no BPC-157, TB-500, sermorelin or other recovery peptide, and the NAD+ line it does sell is not what this site's link to it opens
You are drug-tested: compounded semaglutide and tirzepatide are not on the WADA prohibited list, but they are unapproved compounded preparations with no batch certificate published, which is its own problem for a tested athlete
You want to know before paying whether lab work is included, or whether the price holds as your dose rises — neither is published, and there is no pre-purchase dose selector

What it actually costs

What they advertise

"$139 first month, then $199/month" for compounded semaglutide and "$179 first month, then $299/month" for tirzepatide, printed on the landing pages, the treatment pages, the homepage FAQ and the live medication-select screen — the same four figures on every surface. Brand-name is priced beside them and billed monthly: Zepbound $1,069, Ozempic $1,299, Wegovy $1,349, Mounjaro $1,349.

What you actually pay, month to month

$199/month is $597 billed every 12 weeks, and $299/month is $897 every 12 weeks — Pallas prints the quarterly figure right next to the monthly one, so nothing is hidden. But there is no monthly rung to pick instead, and 12 weeks is 84 days: the charge recurs 4.348 times a year, not four. Steady-state cost is 4.348 × $597 = $2,596 a year, about $216/month for semaglutide, and 4.348 × $897 = $3,900 a year, about $325/month for tirzepatide. Year one, which is one 4-week intro period plus four 12-week blocks, runs $2,527 ($210.58/mo) and $3,767 ($313.92/mo).

The commitment trap

The advertised "/mo" figure is a 12-week prepay divided by three, and it is the only cadence sold — the funnel renders no term selector at all, because `isBundledSlug` is true for both compounded GLP-1 slugs and the cadence UI is suppressed. Two consequences follow. The cash-flow one: after a $139 first payment, the next charge is $597 in a single payment four weeks later. And the arithmetic one: dividing an 84-day cycle by three months understates the ongoing rate by about 8.7%.

Money you will meet later

$139 and $179 are first-period intro rates covering the first four weeks only, and the sitewide "Up to $120 off your first month" banner is a discount rather than a price
$5 is deducted from each refunded payment for purchases made on or after 14 July 2026 — never on clinician-declined or unfulfilled orders, which are refunded in full
In the eight jurisdictions requiring a video visit, checkout collects a $60 deposit instead of the first payment and credits it to the first order; it is refunded if you are declined or cancel before a clinical decision, but may be retained if you neither attend nor reschedule the visit
Insurance is never accepted, so the brand-name route at $1,069–$1,349 a month is cash-pay in full
Whether baseline or follow-up lab work is included or billed extra is not published anywhere on the site

Checked live on Pallas Health's own site at https://www.pallashealth.co/lp/weight-loss in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Pallas Health bundles in, and what it does not.

Clinician consult

Bundled

The checkout labels the first payment "4-week program trial · Medication + provider care", and the renewal note describes the charge as covering "your 12-week refill supply and ongoing care". Intake is free until a clinician makes a decision, and a declined applicant is refunded in full.

Bloodwork / labs

Not published anywhere on the site

— neither required, offered, nor priced. There is no lab step in the intake, which is consistent with the fully asynchronous model in 43 states, and it also means no baseline bloodwork is taken before treatment.

Follow-ups and dose changes

Described as included: "ongoing check-ins" and care-team messaging are named in the plan summary rather than sold separately. No dose-change fee is published, and the FAQ says the price does not rise with dose — a claim that cannot be tested before purchase, because there is no pre-purchase dose selector.

Human support

A care team reachable by message, and nothing more specific

No dietitian, nurse or coach is named or offered.

Injection supplies

Not itemised

The protocol is a weekly subcutaneous injection, so confirm whether syringes, needles and swabs are in the box before ordering.

Shipping

Free, and only when a clinician prescribes

— stated in the plan's own benefits list.

Pharmacy, labs and oversight

The pharmacy

Six, named in public, which is more than any other company reviewed on this site. /clinical states plainly that Pallas "does not own or operate a pharmacy" and lists Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills Pharmacy as the partners that may fill a prescription "depending on the medication, the patient's shipping state, and current capacity". The Terms describe that network as including "503A compounding pharmacies, 503B outsourcing facilities, and (when clinically appropriate) traditional retail or specialty pharmacies". So the names are checkable and the facility type is not: three categories are named collectively, and none is attached to a product or an order. Checked against FDA's live warning-letter index in August 2026 with a positive control in the same run, one of the six carries a letter — Belmar, addressed as "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy", issued 31 March 2023 over compounding practices and CLOSED OUT by FDA on 30 October 2023. Pallas itself screened clean under its own name, its domain, its operator Brentmoor, Inc. and its clinical platform CareValidate.

Oversight

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

All 50 states and Washington D.C., published with the carve-out named rather than buried: care is fully asynchronous in 43 states, while Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C. require one video visit. The checkout enforces it — a shipping address outside the state you were assessed in is rejected — and 52 per-state pages are published.

The honest cons

The part they would rather you skipped

There is no monthly plan, and the number Pallas advertises as a monthly rate is a prepayment divided by the wrong figure. The only purchasable configuration is $597 for semaglutide or $897 for tirzepatide every twelve weeks, so the second charge you meet is the full quarterly amount, in one payment, four weeks in. Twelve weeks is 84 days, which recurs 4.348 times a year rather than four — so the real ongoing cost on Pallas's own terms is about $216 and $325 a month, roughly 8.7% above what it advertises. Nothing about that requires bad faith. "12 weeks is 3 months" is common shorthand, and it happens to round in the seller's favor every time.

No month-to-month option and no term selector at all — the only cadence sold is a 12-week prepay
The advertised "/mo" figure divides an 84-day cycle by three months, understating the ongoing cost by about 8.7% ($216 rather than $199; $325 rather than $299)
The second charge is the full $597 or $897, in one payment, four weeks after the discounted first period
$139 and $179 are intro rates, and the sitewide "Up to $120 off your first month" banner is a discount rather than a price
Only two clinicians are named site-wide, and the footer's "Provider directory" link resolves to a section naming the same two — the actual prescribing network, Lion MD's affiliated professional corporations, is not published
Six pharmacies are named and none is tied to a product or an order, and the Terms name three regulatory categories at once, so the facility type behind a given vial is unknowable
One of those six, Belmar, carries an FDA warning letter issued March 2023 over compounding practices — closed out by FDA in October 2023
Cash-pay only, with insurance never accepted; the brand-name route runs $1,069–$1,349 a month
Lab work and dose-based pricing are simply not published, and the footer disclaims some of the site's own content as AI-generated with no warranty of accuracy
The "4.8" rating in the funnel has no published source, and the before-and-after stories carry an actors-or-models caveat

None of this is unique to Pallas Health — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.

How it compares

The providers we rank on our semaglutide provider ranking — the most specific ranking Pallas Health sits on — in the order that ranking ranks them. It sells into other categories too; see the rankings listed above under the verdict.

12 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

The evidence

The tools

Visit Pallas Health All provider reviews

Facts on this page reflect Pallas Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Pallas Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.